908 Devices Inc. (MASS)
Market Cap | 261.50M |
Revenue (ttm) | 46.85M |
Net Income (ttm) | -33.56M |
Shares Out | 32.05M |
EPS (ttm) | -1.07 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 3,969 |
Open | 8.14 |
Previous Close | 8.05 |
Day's Range | 8.05 - 8.15 |
52-Week Range | 6.38 - 26.00 |
Beta | 0.62 |
Analysts | Buy |
Price Target | 17.34 (+114.47%) |
Earnings Date | May 8, 2023 |
About MASS
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extra... [Read more]
Financial Performance
In 2022, 908 Devices's revenue was $46.85 million, an increase of 11.01% compared to the previous year's $42.21 million. Losses were -$33.56 million, 51.4% more than in 2021.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $17.34, which is an increase of 114.47% from the latest price.
News

908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Cowen 43r...

908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the four...

908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced the launch of MAVEN, a device for on-line m...

MX908 Device Enables Correctional Facility Personnel to Quickly Identify Illegal Drugs in Incoming Mail
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today shared details on the positi...

908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) delivered earnings and revenue surprises of 9.09% and 0.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results f...

908 Devices Records Strong Momentum in Life Sciences Sector
BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, continues to equip its life science custo...

908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the availability of ...

908 Devices to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate ...

908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan...

908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis
BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announced that its collaboration with CPI is demons...

908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 2.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Reports Second Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for...

908 Devices Acquires TRACE Analytics, Enabling On-line Bioanalytics
BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces that it has completed the...

908 Devices to Participate in the Canaccord Genuity 42nd Annual Growth Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will be participa...

908 Devices to Report Second Quarter 2022 Financial Results on August 9, 2022
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan...

908 Devices Showcases Technology for Accelerating Mass Spec Workflows in Presentations at ASMS
BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, is showcasing the use of its high-pressur...

908 Devices to Participate in the William Blair 42nd Annual Growth Stock Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will be participa...

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 8.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for...

908 Devices Advances MX908 Handheld Device Capabilities
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced updates to its MX908...

908 Devices Partners with Key Biomanufacturing Innovation Center
BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, is partnering with the Advanced Mammalian Biomanufa...

908 Devices and CPI Team on Cell Culture Media Optimization for Improved Process Control in Bioprocessing Applications
BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, is collaborating with UK-based, deep-tech innovatio...